Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
Department of Laboratory Medicine and Pathology, University of Minnesota Medical Center, Minneapolis, MN, United States of America.
PLoS One. 2019 Dec 17;14(12):e0226436. doi: 10.1371/journal.pone.0226436. eCollection 2019.
Infectious mononucleosis (IM) is a common adverse presentation of primary infection with Epstein-Barr virus (EBV) in adolescence and later, but is rarely recognized in early childhood where primary EBV infection commonly occurs. It is not known what triggers IM, and also not why IM risk upon primary EBV infection (IM attack rate) seemingly varies between children and adolescents. IM symptoms may be severe and persist for a long time. IM also markedly elevates the risk of Hodgkin lymphoma and multiple sclerosis for unknown reasons. The way IM occurrence depends on age and sex is incompletely described and hard to interpret etiologically, because it depends on three quantities that are not readily observable: the prevalence of EBV-naϊve persons, the hazard rate of seroconverting and the attack rate, i.e. the fraction of primary EBV infections that is accompanied by IM. We therefore aimed to provide these quantities indirectly, to obtain epidemiologically interpretable measures of the dynamics of IM occurrence to provide etiological clues.
We used joint modeling of EBV prevalence and IM occurrence data to provide detailed sex- and age-specific EBV infection rates and IM attack rates and derivatives thereof for a target population of all Danes age 0-29 years in 2006-2011. We demonstrate for the first time that IM attack rates increase dramatically rather precisely in conjunction to typical ages of puberty onset. The shape of the seroconversion hazard rate for children and teenagers confirmed a priori expectations and underlined the importance of what happens at age 0-2 years. The cumulative risk of IM before age 30 years was 13.3% for males and 22.4% for females. IM is likely to become more common through delaying EBV infection in years to come.
The change in attack rate at typical ages of puberty onset suggests that the immunologic response to EBV drastically changes over a relatively short age-span. We speculate that these changes are an integrated part of normal sexual maturation. Our findings may inform further etiologic research into EBV-related diseases and vaccine design. Our methodology is applicable to the epidemiological study of any infectious agent that establishes a persistent infection in the host and the sequelae thereof.
传染性单核细胞增多症(IM)是青少年及以后初次感染 EBV 时常见的不良表现,但在原发性 EBV 感染常见的幼儿中很少被发现。目前尚不清楚是什么引发了 IM,也不知道为什么原发性 EBV 感染(IM 发病率)的风险似乎在儿童和青少年之间存在差异。IM 症状可能很严重并持续很长时间。IM 还明显增加了霍奇金淋巴瘤和多发性硬化症的风险,原因不明。由于取决于三个不易观察到的量,即 EBV 初发者的流行率、血清转化的危险率和发病率(即原发性 EBV 感染伴 IM 的比例),因此不完全描述和难以从病因学上解释 IM 发生的方式取决于年龄和性别。因此,我们旨在间接地提供这些数量,以获得可用于解释 IM 发生动态的流行病学可解释措施,从而提供病因线索。
我们使用 EBV 流行率和 IM 发生数据的联合建模,为 2006-2011 年丹麦所有 0-29 岁人群提供了详细的性别和年龄特异性 EBV 感染率和 IM 发病率及其衍生指标。我们首次证明,IM 发病率与青春期典型年龄的变化非常精确地相关。儿童和青少年血清转化率危险率的形状证实了先验预期,并强调了 0-2 岁时发生的事情的重要性。30 岁之前 IM 的累积风险为男性 13.3%,女性 22.4%。随着未来几年 EBV 感染的延迟,IM 可能变得更加普遍。
在青春期典型年龄时发病率的变化表明,对 EBV 的免疫反应在相对较短的年龄范围内发生了巨大变化。我们推测这些变化是正常性成熟的一个组成部分。我们的研究结果可能为 EBV 相关疾病的进一步病因学研究和疫苗设计提供信息。我们的方法适用于对在宿主中建立持续感染及其后果的任何传染性病原体的流行病学研究。